# US 2014/0271810 A1 · Hair treatment systems and methods using peptides and other compositions

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2014/0271810 A1
- Document ID: US20140271810A1
- Status: Published application
- Kind: A1
- Application number: 13/801,488
- Filed: 2013-03-13
- Published: 2014-09-18
- Earliest claimed: 2013-03-13
- Assignees: Transdermal Biotechnology, Inc.
- Applicants: Transdermal Biotechnology, Inc.
- Inventors: Nicolas V. Perricone
- Web page: https://patentgrep.com/patent/US20140271810A1

## CPC

- A61K 9/0014: {Skin, i.e. galenical aspects of topical compositions (non-active ingredients are additionally classified in A61K47/00; A61K9/0009, A61K9/0021, A61K9/7015, A61K9/7023 take precedence; cosmetic preparations A61K8/00, A61Q; preparations for wound dressings or bandages A61L26/00)}
- A61K 8/06: Emulsions
- A61K 8/19: containing inorganic ingredients
- A61K 8/553: {Phospholipids, e.g. lecithin}
- A61K 8/64: Proteins; Peptides; Derivatives or degradation products thereof
- A61K 33/00: Medicinal preparations containing inorganic active ingredients
- A61K 38/066: {TRH, thyroliberin, thyrotropin releasing hormone}
- A61L 2/00: Disinfection or sterilisation of materials or objects, in general; Accessories therefor
- A61L 9/00: Disinfection, sterilisation or deodorisation of air (body deodorants A61Q15/00; purifying air by respirators A62B, A62D9/00; separating dispersed particles from gases or vapours B01D45/00 - B01D51/00, B03C3/00; chemical or biological purification of waste gases B01D53/34; production of ozone C01B13/10; air-conditioning systems incorporating sterilisation F24F3/16, F24F8/20)
- A61P 17/14: for baldness or alopecia
- A61Q 7/00: Preparations for affecting hair growth
- A61K 2800/74: Biological properties of particular ingredients
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61Q: SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS

## Abstract

The present invention generally relates to compositions and methods for transdermal delivery, and treatment of hair related conditions. The compositions can be used in a variety of applications, including causing or promoting hair growth and/or hair pigmentation. In some cases, the composition may include nitric oxide and/or peptides. The nitric oxide and/or peptide may be present within a first phase comprising a lecithin, such as phosphatidylcholine. In certain embodiments, the lecithin is present in liposomes, micelles, or other vesicles containing nitric oxide, peptides, or both. The composition can take the form of a gel, a cream, a lotion, an ointment, a solution, a solid “stick,” etc., that can be rubbed or sprayed onto the skin, e.g., onto the scalp, or other suitable portion of the skin. Other aspects of the present invention are generally directed to methods of making or using such compositions, methods of promoting such compositions, kits including such compositions, or the like.

## Claims

### Claim 1

A method, comprising:
administering, to the skin and/or hair of a subject, a composition comprising an effective amount of thyrotropin-releasing hormone (TRH) and molecular nitric oxide to increase hair growth, and a carrier having a phosphatidylcholine component entrapping the molecular nitric oxide, wherein the molecular nitric oxide is present within the carrier as a gas or bound by hydrogen bonds or van der Waals forces.

### Claim 2 (depends on 1)

The method of claim 1, comprising administering the composition to the skin or hair of the head of the subject.

### Claim 3 (depends on 1)

The method of claim 1, wherein the subject has greying hair.

### Claim 4 (depends on 1)

The method of claim 1, wherein the subject has thinning hair.

### Claim 5 (depends on 1)

The method of claim 1, wherein the subject has baldness.

### Claim 6 (depends on 1)

The method of claim 1, wherein the subject has androgenic alopecia.

### Claim 7 (depends on 1)

The method of claim 1, wherein the phosphatidylcholine carrier stabilizes the nitric oxide at a temperature at or lower than 80° C.

### Claim at position 8

8-10. (canceled)

### Claim 11 (depends on 1)

The method of claim 1, wherein the composition comprises a liquid crystal structure comprising the phosphatidylcholine.

### Claim 12 (depends on 11)

The method of claim 11, wherein at least a portion of the liquid crystal structure is multilamellar.

### Claim 13

A method, comprising contacting the skin and/or hair of a subject with a composition comprising:
an emulsion comprising a first phase comprising TRH, molecular nitric oxide, and lecithin, and a second phase comprising an emulsifier, wherein the lecithin is present at least about 0.25% by weight of the composition, wherein the first phase comprises no more than about 250 ppm of water by weight of the composition, and wherein the molecular nitric oxide is present within the emulsion as a gas or bound by hydrogen bonds or van der Waals forces to the lecithin.

### Claim 14 (depends on 13)

The method of claim 13, comprising administering the composition to the skin or hair of the head of the subject.

### Claim 15 (depends on 13)

The method of claim 13, wherein the subject has greying hair.

### Claim 16 (depends on 13)

The method of claim 13, wherein the subject has thinning hair.

### Claim 17 (depends on 13)

The method of claim 13, wherein the subject has baldness.

### Claim 18 (depends on 13)

The method of claim 13, wherein the subject has androgenic alopecia.

### Claim 19 (depends on 13)

The method of claim 13, wherein the first phase forms discrete vesicles contained within the second phase.

### Claim 20 (depends on 19)

The method of claim 19, wherein the first phase forms liposomes contained within the second phase.

### Claim 21 (depends on 20)

The method of claim 20, wherein the first phase forms multilamellar liposomes contained within the second phase.

### Claim at position 20

22-23. (canceled)

### Claim 24 (depends on 13)

The method of claim 13, wherein the nitric oxide is present at least about 0.5% by weight of the composition without nitric oxide.

### Claim at position 22

25-26. (canceled)

### Claim 27 (depends on 13)

The method of claim 13, wherein at least some of the nitric oxide is present within the first phase bound to phosphatidylcholine.

### Claim at position 24

28-31. (canceled)

### Claim 32 (depends on 13)

The method of claim 13, wherein the lecithin comprises a phosphatidylcholine.

### Claim at position 26

33-35. (canceled)

### Claim 36 (depends on 32)

The method of claim 32, wherein at least some of the phosphatidylcholine comprises a polyenylphosphatidylcholine.

### Claim at position 28

37-41. (canceled)

### Claim 42 (depends on 13)

The method of claim 13, wherein the first phase comprises a fatty acid ester.

### Claim at position 30

43-51. (canceled)

### Claim 52

A method, comprising:
administering, topically to the skin of a subject, a composition comprising an effective amount of thyrotropin-releasing hormone (TRH) to increase hair growth, wherein the composition is a cream, a gel, a lotion, or an ointment.

### Claim 53 (depends on 52)

The method of claim 52, comprising administering the composition to the skin or hair of the head of the subject.

### Claim 54 (depends on 52)

The method of claim 52, wherein the subject has thinning hair or baldness.

### Claim 55 (depends on 52)

The method of claim 52, wherein the subject has androgenic alopecia.

### Claim 56 (depends on 52)

The method of claim 52, wherein the composition comprises phosphatidylcholine.

### Claim 57 (depends on 56)

The method of claim 56, wherein the composition comprises a liquid crystal structure comprising the phosphatidylcholine.

### Claim 58 (depends on 57)

The method of claim 57, wherein at least a portion of the liquid crystal structure is multilamellar.

### Claim 59 (depends on 56)

The method of claim 56, wherein at least some of the phosphatidylcholine comprises a polyenylphosphatidylcholine.

### Claim 60 (depends on 52)

The method of claim 52, wherein the composition is a cream.
